Cargando…
Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1
STUDY OBJECTIVES: The diagnosis of narcolepsy type 1 (NT1) is based upon the presence of cataplexy and/or a cerebrospinal fluid (CSF) hypocretin-1/orexin-A level ≤ 110 pg/mL. We determined the clinical and diagnostic characteristics of patients with intermediate hypocretin-1 levels (111–200 pg/mL) a...
Autores principales: | van der Hoeven, Adrienne Elisabeth, Fronczek, Rolf, Schinkelshoek, Mink Sebastian, Roelandse, Frederik Willem Cornelis, Bakker, Jaap Adriaan, Overeem, Sebastiaan, Bijlenga, Denise, Lammers, Gert Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113791/ https://www.ncbi.nlm.nih.gov/pubmed/35554594 http://dx.doi.org/10.1093/sleep/zsac052 |
Ejemplares similares
-
Hypocretin-1 measurements in cerebrospinal fluid using radioimmunoassay: within and between assay reliability and limit of quantification
por: van der Hoeven, Adrienne Elisabeth, et al.
Publicado: (2022) -
The development of hypocretin deficiency in narcolepsy type 1 can be swift and closely linked to symptom onset: clues from a singular case
por: Schinkelshoek, Mink Sebastian, et al.
Publicado: (2019) -
Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy
por: Seifinejad, Ali, et al.
Publicado: (2023) -
High frequency repetitive transcranial magnetic stimulation over the motor cortex: No diagnostic value for narcolepsy/cataplexy
por: Overeem, S., et al.
Publicado: (2007) -
What triggered narcolepsy: H1N1 vaccination, virus, or both? Important lessons learned from China
por: Gool, Jari K, et al.
Publicado: (2023)